Clinical Trial Update: Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating mitomycin C with hyperthermia and intravesical mitomycin C for recurrent bladder cancer has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Mark Dewhirst | Conditions: Transitional Cell Carcinoma of Bladder, Superficial Bladder Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2011-08-30